Role of the growth factors IGF-1 and TGF-beta 1 in the endometrial adenocarcinoma

International Journal of Medicine, Biology and the Environment

Volumn 29, Issue 2, 2001, Pages 193-200

  Perlino, Elda ^a   Lovecchio, Mariarosaria ^a   Loverro, Giuseppe ^a   Maiorano, Eugene ^a   Selvaggi, Luigi ^a   Marra, Ersilia ^a  

^a UNIVERSITY OF BARI   (Italy)

Author keywords

Adenocarcinoma; Endometrium; Gene expression; IGF 1; Immunohistochemistry; TGF 1

Indexed keywords

GROWTH FACTOR; GROWTH FACTOR RECEPTOR; MESSENGER RNA; SOMATOMEDIN; STEROID HORMONE; TRANSFORMING GROWTH FACTOR BETA1;

CANCER GROWTH; CARCINOGENESIS; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; ENDOMETRIUM; ENDOMETRIUM CARCINOMA; FEMALE; GENE EXPRESSION; GENITAL SYSTEM; HORMONE ACTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VIVO STUDY; MITOGENESIS; PARACRINE SIGNALING; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN SYNTHESIS; REGULATORY MECHANISM; REVIEW; TISSUE DISTRIBUTION; TUMOR DIFFERENTIATION;

EID: 0035412525     PISSN: 1128935X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (54)

1. Dahiya, R., Lee, C., Haughney, P.C., Chui, R., Ho, R. and Deng, G. Differential gene expression of Transforming growth factors alpha and beta, epidermal growth factor, keratinocyte growth factor, and their receptors in fetal and adult human prostatic tissues and cancer cell lines. Urology 48, 963-970 (1996).
2. Hunter, H. Oncoprotein networks. Cell 88, 333-346 (1997).
3. Cline, M.J. Overview: the nature of malignancy. In: Apoptosis and cell cycle control in cancer (Shaun, N., Thomas, B. ed.), pp. 131-146, Latchman, London (1996).
4. Berchuck, A. and Boyd, J. Molecular basis of endometrial cancer. Cancer (suppl) 76, 2034-2040 (1995).
5. Boyd, J. Protooncogenes and growthfactors in steroid hormone induced growth and differentiation, Khan S.A. and Stancel G. M., CRC Press (1994).
6. Smith, S.K. Growth factors in the human endometrium. Hum Reprod Update 9, 936-946 (1994).
7. Rutanen, E.M, Insulin-like growth factors in endometrial function. Gynaecol Endocrinol 12(6), 399-406 (1998).
8. Sherman, M.E. Theories of endometrial carcinogenesis: a multidisciplinary approach. Mod Pathol 13(3), 295-308 (2000).
9. Tabibzadeh, S. Human Endometrium: An active site of cytokine production and action. Endocr Rev 12, 272-290 (1991).
10. Giudice, L.C. Growth factors and growth modulators in human uterine endometrium: their potential relevance to reproduction medicine. Fertil Steril 61, 1-17 (1994).
11. Cavanagh, D., Fiorica, J.V., Hoffman, M.S., Durfee, J., Nicosia, S.V. Adenocarcinoma of endometrium: an institutional review. Cancer Control Journal 6(4), (2000).
12. Gurpide, E. Endometrial cancer: biochemical and clinical correlates. J Natl Cancer Inst 83, 405-416 (1991).
13. Culig, Z., Hobisch, A., Cronauer, M.V., Radmayr, C., Hittmair, A., Zhang, J., Thurnher, M., Bartsch, G. and Klocker, H. Regulation of prostatic grow and function by peptide growth factors. The Prostate 28, 392-405 (1996).
14. Rutanen, E.M. Insulin-like growth factors and insulin-like growth factor binding proteins in the endometrium effect of intrauterine levonorgestrel delivery. Human Reprod (suppl) 3, 173-181 (2000).
15. Daughaday, W.H. and Rotwein, P. Insulin-like factors I e II. Peptide, messenger ribonucleicacid and gene structures, serum and tissue concentrations. Endocrinol Rev 10, 68-91 (1989).
16. Jones, J. and Clemmons, D.R. Insulin-like growth factors and their binding proteins biological actions. Endocrinol Rev 16, 3-34 (1995).
17. Parrizas, M. and Le Roith, D. Insulin-like growth factor-1 inhibition of apoptosis is associated with increased expression of the bcl-XL gene product. Endocrinology 138, 1355-1358 (1997).
18. Claire Stewart, E.H. and Rotwein, P. Growth, differentiation, and survival: multiple physiological functions for insulin-like growth factors. Physiol Rev 76, 1005-1026 (1996).
19. Giudice, L.C., Dsupin B.A., Jin, I.H., Vu, T.H. and Hoffman, A.R. Differential expression of mRNAs encoding insulin-like growth factors and their receptors in human uterine endometrium and decidua. J Clin Endocrinol Metab 76, 1115-1122 (1993).
20. Talavera, F., Reynolds, R.K., Roberts, J.A. and Menon, K.M.J. Insulin-like growth factor-I receptors in normal and neoplastic human endometrium. Cancer Res 50, 3019-3024 (1990).
21. Giudice, L.C., Dsupin, B.A. and Irwin, J.C. Steroid and peptide regulation of insulin-like growth factor binding proteins secreted by human endometrial stromal cells is dependent on stromal differentiation. J Clin Endocrinol Metab 75, 1235-1241 (1992).
22. Rutanen, E.M., Pekonen, F., Nyman, T. and Wahlstrom, T. Insulin-like growth factors and their binding proteins in benign and malignant uterine disease. Growth Regul 3, 74-77 (1993).
23. Wang, H.S., Wang, T.H. and Soong, Y.K. Elevation of insulin-like growth factor-binding protein-1 mRNA expression following hormone replacement therapy. Hum Repr 15, 50-54 (2000).
24. Reynolds, R.K., Owens, C.A., Roberts, J.A., Hopkins, M.P. and Menon, K.M.J. Autocrine production of TGF-α and IGF-I causes proliferation in endometrial carcinoma cell lines. Gynecol Oncol 54, 106-107 (1994).
25. Maiorano, E., Loverro, G., Viale, G., Giannini, T., Napoli, A. and Perlino, E. Insulin-like growth factor-1 expression in normal and diseased endometrium. Int J Cancer 80, 188-193 (1999).
26. Loverro, G., Perlino, E., Maiorano, E., Ricco, R., Marra, E., Cazzolla, A., Giannini, T. and Selvaggi, L.. Functional Aspects of post-menopausal endometrium Maturitas, 31, 179-184 (1999).
27. Laatikainen, T.J., Tomas, E.I. and Voutilainen, R.J. The expression of insulin-like growth factor and its binding protein mRNA in the endometrium of post-menopausal patients with breast cancer receiving tamoxifen. Cancer 76, 1406-1410 (1995).
28. Rutanen, E.M., Nyman, T., Lehtovirta, P., Ammala, M. and Pekonen, F. Suppressed expression of insulin-like growth factor binding protein 1 mRNA in the endometrium: a molecular mechanism associating endometrial cancer with its risk factors. Int J Cancer 59, 307-312 (1994).
29. Reynolds, R.K., Owens, C.A. and Roberts, J.A. Cultured endometrial cells exhibit autocrine growth factor stimulation that is not observed in cultured normal endometrial cells. Gynecol Oncol 60, 380-386 (1996).
30. Elkas, J., Gray, L.K., Howard, L., Petit, N., Pohl, J. and Armstrong A. The effects of tamoxifen on endometrial insulin-like growth factor-1 expression. Obstet Gynecol 91, 45-50 (1998).
31. Pekonen, F., Nyman, T., And Rutanen, E.M. Human endometrial adenocarcinoma cell lines HEC 1B and KLE secrete insulin-like growth factor binding protein-1 and contain IGF-I receptors. Mol Cell Endocrinol 75, 81-87 (1991).
32. Ayabe, T., Tsutsumi, O., Sakai, H., Yoshikawa, H., Yano, T., Kurimoto, F. and Taketani, Y. Increased circulating levels of insulin-like growth factor-I and decreased circulating levels of insulin-like growth factor binding protein-1 in postmenopausal women with endometrial cancer. Endocrinol J 44, 419-424 (1997).
33. http://www.genpat.uu.se/persons/ata/txtavh.html
34. Barrack, E.R. TGF-beta in prostate cancer: a growth inhibitor that can enhance tumorigenicity. The Prostate 31, 61-70 (1997).
35. Roberts, A.B., Sporn, M.B. The transforming growth factor-βs. In: Peptide growth factors and their receptors (Sporn, M.B., Roberts, A.B. eds) pp. 419-472, Springer-Verlag, Heidelberg (1990).
36. Glick, A.B., Lee, M.M., Darwiche, N., Kulkarni, A.B., Karlsson, S. and Yuspa, S.H. Target deletion of the TGF-β1 gene causes rapid progression to squamous cell carcinoma. Genes Dev 8, 2429-2440 (1994).
37. Derynck, R., Goeddel, D.V., Ullrich, A., Gutterman, J.U., Williams, R.D., Bringman, T.S. and Berger, W.H. Synthesis of messenger RNAs for transforming growth factors α and β and the epidermal growth factor receptor by human tumors. Cancer Res 47, 707-712 (1987).
38. Coffey, R.J., Goustin, A.S., Soderquist, A.M., Shipley, G.D., Wolfshohl, J., Carpenter, G. and Moses, H.L. Transforming growth factor α and β expression in human colon cancer lines: implications for an autocrine model. Cancer Res 47, 4590-4594 (1987).
39. Paulin, C., Avallet, O., Tardy, F., Saez, J., Fusco, A. and Fabien, N. Production of TGF-β and HGF receptor by a differentiated papillary thyroid carcinoma cell line (B-CPAP): implication in malignancy. Int J Oncol 7, 657-660 (1995).
40. Christeli, E., Zoumpourlis, V., Kiaris, H., Ergazaki, M., Vassilaros, S. and Spandidos, D.A. TGF-β1 overexpression in breast cancer: correlation with clinicopathological data. Oncol Reports 3, 1115-1118 (1996).
41. Truong, L.D., Kadmon, D., McCune, B.K., Flanders, K.C., Scardino, P.T. and Thompson, T.C. Association of transforming growth factor β1 with prostate cancer. Human Pathol 24, 4-9 (1993).
42. Friess, H., Yamanaka, Y., Buchler, M., Ebert, M., Beger, H.G., Gold, L.I. and Kore, M. Enhanced expression of transforming growth factor β isoforms in pancreatic cancer correlates with decreased survival. Gastroenterol 105, 1846-1856 (1994).
43. Perlino, E., Ciampolillo, A., Maiorano, E., Pannone, E., Viale, G., Giorgino, R. and Marra, E. Transforming growth factor-β1 (TGF-β1) expression in proliferating thyroid disease. Int J Oncol 9, 83-88 (1996).
44. Loverro, G., Cormio, G., Perlino, E., Vicino, M., Cazzolla, A. and Selvaggi, L. Transforming Growth Factor-beta1 in Hemangioma of the Ovary. Gynecol Obstet Invest. 46, 210-213( 1998).
45. Perlino, E., Tommasi, S., Moro, L., Bellizzi, A., Marra, E., Casavola, V. and Reskin, S. TGF-β1 and IGF-1 expression are differently regulated by serum in metastatic and non metastatic human breast cancer cells Int. J of Oncology, 16, 155-160 (2000).
46. McMahon, J.B., Richards, W.L., del Campo, A.A., Song, M.K. and Thorgiersson, S.S. Differential effects of transforming growth factor-β on proliferation of normal and malignant rat liver epithelial cells in culture. Cancer Res 46, 4665-4671 (1986).
47. Reiss, M. and Sartorelli, A.C. Regulation of growth and differentiation of human keratinocyte by type β transforming growth factor and epidermal growth factor. Cancer Res 47, 6705-6709 (1987).
48. Niitsu, Y., Urushizaki, Y., Koshida, Y., Terui, K., Mahara, K., Kohgo, Y. and Urushizaki, I. Expression of TGF-β gene in adult T-cell leukemia. Blood 71, 263-266 (1988).
49. Kimchi, A., Wang, X.F., Weinberg, R.A., Cheietz, S. and Massagué, J. Absence of TGF-β receptor and growth inhibitory responses in retinoblastoma cells. Science 240, 196-198 (1988).
50. Jetten, A.M., Shirley, J.E. and Stoner, G. Regulation of proliferation and differentiation of respiratory tract epithelia] cells by TGF-β. Exp Cell Res 167, 539-549 (1986).
51. Murphy, L.J., Gong, Y. and Murphy, L.C. Growth factors in normal and malignant tissue. Ann NY Acad Sci 622, 383-401 (1991).
52. Tang, X.M., Zhao, Y., Rossi, M.Y., Abu-Rustum, R.S., Ksander, G.A. and Ghegini, N. Expression of Transforming Growth Factor-β (TGF-β) isoforms and TGF-β type II receptor messenger ribonucleic acid and protein, and the effect of TGF-βs on endometrial stromal cells growth and protein degredation in vitro. Endocrinol 135, 450-459 (1994).
53. Perlino, E., Loverro, G., Maiorano, E., Giannini, T., Cazzolla, A., Napoli, A., Fiore, M.G., Ricco, R., Marra, E. and Selvaggi, L. Down- regulated expression of transforming growth factor-beta 1 mRNA in endometrial carcinoma British J Cancer, 77, 1260-1266 (1998).
54. Boyd, J.A. and Kaufman, D.G. Expression of Transforming Growth Factor β1 by human endometrial carcinoma cell lines: inverse correlation with effect on growth rate and morphology. Cancer Res 50, 3394-3399